Questions Arise as Hims & Hers (HIMS) Had Revenue Decline on a Sequential Basis
August 25, 2025
Hims & Hers (HIMS) had revenue decline on a sequential basis, with a slew of other news that could mean slowing demand.
Research Reports
Hims & Hers (HIMS) Introduces Hair Growth Gummies for Women to its Lineup
June 19, 2025
Hims & Hers (HIMS) continues to innovate new treatments, like NEW hair growth gummies that are specifically designed for women.
Hims & Hers (HIMS) Jumps as the Company Will Sell Nova Nordisk’s Wegovy
April 29, 2025
News that Hims & Hers (HIMS) will be selling the Wegovy weight loss treatment on its platform sent HIMS stock higher today.
Hims & Hers (HIMS) Stock Climbs on a Plethora of Good News & Results
December 17, 2024
Hims & Hers (HIMS) is an online pharmacy with doctors who prescribe drugs for weight loss, hair loss sexual issues, and more.
Hims & Hers (HIMS) Continues to Produce Exceptional Results; But Risks Remain
October 9, 2024
Hims & Hers (HIMS) is growing rapidly and profits have been picking up. But the company’s weight loss drug comes with scrutiny.
Hims & Hers (HIMS) is Becoming a Disruptor in Providing Digital Healthcare
May 30, 2024
Hims & Hers Helalth (HIMS) has been in the news for its weight loss drug. But this is just one of many health solutions HIMS provides.
Earnings
HIMS 2025 Q4
November 3, 2025
Hims & Hers Health (HIMS) is expected to report qtrly profits (EPS) and revenues:
- Profits Estimates: $0.12 vs. $0.32 = -63%
- Revenue Est: +44%
HIMS 2025 Q3
August 4, 2025
Hims & Hers Health (HIMS) reports qtrly profits (EPS) and revenues:
- Reported: $0.17 vs. $0.06 = +183%
- Estimates: $0.14 vs. $0.06 = +133%
- Beat the street by $0.03
- Revenue: +73%
- Revenue Est: +74%
HIMS 2025 Q2
May 5, 2025
Hims & Hers Health (HIMS) reports qtrly profits (EPS) and revenues:
- Reported: $0.20 vs. $0.05 = +300%
- Estimates: $0.12 vs. $0.05 = +140%
- Beat the street by $0.08
- Revenue: +111%
- Revenue Est: +95%
HIMS 2025 Q1
February 24, 2025
Hims & Hers Health (HIMS) reports qtrly profits (EPS) and revenues:
- Reported: $0.11 vs. $0.01 = +999%
- Estimates: $0.09 vs. $0.01 = +800%
- Beat the street by $0.02
- Revenue: +95%
- Revenue Est: +91%
HIMS 2024 Q4
November 4, 2024
Hims & Hers Health (HIMS) reports qtrly profits (EPS) and revenues:
- Reported: $0.32 vs. -$0.04 = +900%
- Estimates: $0.04 vs. -$0.04 = +200%
- Beat the street by $0.28
- Revenue: +77%
- Revenue Est: +67%
HIMS 2024 Q3
August 5, 2024
Hims & Hers Health (HIMS) reports qtrly profits (EPS) and revenues:
- Reported: $0.06 vs. -$0.03 = +300%
- Estimates: $0.04 vs. -$0.03 = +233%
- Beat the street by $0.02
- Revenue: +52%